Meifang Li

1.8k total citations
77 papers, 1.3k citations indexed

About

Meifang Li is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Meifang Li has authored 77 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Oncology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Meifang Li's work include CAR-T cell therapy research (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Epigenetics and DNA Methylation (7 papers). Meifang Li is often cited by papers focused on CAR-T cell therapy research (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Epigenetics and DNA Methylation (7 papers). Meifang Li collaborates with scholars based in China, United States and Hong Kong. Meifang Li's co-authors include Xuan Zhou, Sanfang Tu, Yuhua Li, Lianxi Li, Weiping Jia, Huilin Tu, Junxi Lu, Xiaoli Zhang, Qihang Sun and Yuqian Bao and has published in prestigious journals such as Blood, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Meifang Li

70 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meifang Li China 19 494 428 197 175 162 77 1.3k
Pei Shu China 12 499 1.0× 528 1.2× 133 0.7× 236 1.3× 559 3.5× 37 1.4k
Shuo Yang China 18 415 0.8× 502 1.2× 160 0.8× 73 0.4× 301 1.9× 83 1.2k
Liang Chang China 21 285 0.6× 849 2.0× 87 0.4× 99 0.6× 84 0.5× 58 1.4k
Xiaojun Zhang China 12 310 0.6× 1.2k 2.8× 167 0.8× 141 0.8× 157 1.0× 39 1.8k
Ana I. Flores Spain 21 187 0.4× 754 1.8× 93 0.5× 101 0.6× 175 1.1× 58 1.8k
Shunsuke Uehara Japan 23 753 1.5× 1.8k 4.2× 95 0.5× 341 1.9× 277 1.7× 52 2.7k
Paola Brescia Italy 15 309 0.6× 609 1.4× 57 0.3× 60 0.3× 168 1.0× 28 1.3k
Curtis A. Thorne United States 17 337 0.7× 1.3k 3.0× 64 0.3× 172 1.0× 91 0.6× 32 1.7k
Pamela Plant Canada 21 207 0.4× 1.5k 3.4× 289 1.5× 147 0.8× 90 0.6× 29 1.9k
Keisuke Okabe Japan 19 302 0.6× 618 1.4× 63 0.3× 85 0.5× 104 0.6× 73 1.7k

Countries citing papers authored by Meifang Li

Since Specialization
Citations

This map shows the geographic impact of Meifang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meifang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meifang Li more than expected).

Fields of papers citing papers by Meifang Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meifang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meifang Li. The network helps show where Meifang Li may publish in the future.

Co-authorship network of co-authors of Meifang Li

This figure shows the co-authorship network connecting the top 25 collaborators of Meifang Li. A scholar is included among the top collaborators of Meifang Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meifang Li. Meifang Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Zhang, Yuchen, et al.. (2024). High-throughput screening for optimizing adoptive T cell therapies. Experimental Hematology and Oncology. 13(1). 113–113. 5 indexed citations
5.
Li, Meifang, et al.. (2023). Three new metabolites from the endophyte Fusarium proliferatum T2-10. Natural Product Research. 39(7). 1793–1803. 2 indexed citations
6.
Yang, Li, Meifang Li, Jian Liu, Guangning Nie, & Hongyan Yang. (2023). Altered m6A modification is involved YAP-mediated apoptosis response in 4-vinylcyclohexene diepoxide induced ovotoxicity. Ecotoxicology and Environmental Safety. 262. 115192–115192. 9 indexed citations
7.
Li, Meifang, Shaozhong Li, De Zeng, et al.. (2023). Notch1 promotes resistance to cisplatin by up-regulating Ecto-5′-nucleotidase (CD73) in triple-negative breast cancer cells. Cell Death Discovery. 9(1). 204–204. 11 indexed citations
8.
Chang, Ning, et al.. (2023). Knockdown of MEF2D inhibits the development and progression of B-cell acute lymphoblastic leukemia. Translational Cancer Research. 12(2). 287–300. 4 indexed citations
9.
Chen, Mingyun, Zhihui Zhang, Jiang-Feng Ke, et al.. (2022). Chaetocin attenuates atherosclerosis progression and inhibits vascular smooth muscle cell phenotype switching. Journal of Cardiovascular Translational Research. 15(6). 1270–1282. 10 indexed citations
10.
Yan, Jiaqi, Liang Qian, Xiaoxiao Li, et al.. (2022). Glutathione Synthesis Regulated by CtrA Protects Ehrlichia chaffeensis From Host Cell Oxidative Stress. Frontiers in Microbiology. 13. 846488–846488. 5 indexed citations
11.
Zhou, Xuan, Sanfang Tu, Chunsheng Wang, et al.. (2020). Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas. Frontiers in Immunology. 11. 564099–564099. 41 indexed citations
12.
Xie, Li, Dongdong Cao, Meifang Li, et al.. (2019). Huyang yangkun formula protects against 4-Vinylcyclohexene diepoxide-induced premature ovarian insufficiency in rats via the Hippo–JAK2/STAT3 signaling pathway. Biomedicine & Pharmacotherapy. 116. 109008–109008. 21 indexed citations
13.
Li, Meifang, Yuehui Zhang, Xinhua Wang, et al.. (2017). Cryptotanshinone Regulates Androgen Synthesis through the ERK/c‐Fos/CYP17 Pathway in Porcine Granulosa Cells. Evidence-based Complementary and Alternative Medicine. 2017(1). 11 indexed citations
14.
Wang, Haiying, Qian Li, Meifang Li, et al.. (2016). The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cells. Hematology. 22(4). 208–216. 69 indexed citations
15.
Li, Meifang, Rong Zhang, Tingting Li, et al.. (2015). High Glucose Increases the Expression of Inflammatory Cytokine Genes in Macrophages Through H3K9 Methyltransferase Mechanism. Journal of Interferon & Cytokine Research. 36(1). 48–61. 31 indexed citations
17.
Wu, Xing, Junxi Lu, Yinfang Tu, et al.. (2014). Comparison of carotid and lower limb atherosclerotic lesions in both previously known and newly diagnosed type 2 diabetes mellitus. Journal of Diabetes Investigation. 5(6). 734–742. 18 indexed citations
19.
Liu, Chunming, et al.. (2013). [Sequential reduction and fixation for zygomatic complex fractures].. PubMed. 27(10). 1181–4.
20.
Yin, Chih‐Ming, Bai-Xiang Zou, Meifang Li, & John G. Stoffolano. (1997). Using the Pungent Seed Flesh of the Durian Fruit, Durio zibethinus, to Synchronize the Second Ovarian Cycle of Phormia regina (Diptera: Calliphoridae). Zoological studies. 36(4). 353–359. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026